Teva's Bid To Crack Attorney-Client Privilege Fails

Law360 (November 7, 2008, 12:00 AM EST) -- A federal judge has denied Teva Pharmaceuticals USA Inc.'s bid to force a Merck & Co. Inc. affiliate to produce privileged documents related to Merck's alleged fraud in obtaining the patent for allergy drug Singulair.

Judge John J. Hughes of the U.S. District Court for the District of New Jersey on Wednesday denied the motion to compel after finding Teva had failed to show Barbados-based Merck Sharp & Dohme Pharmaceuticals SRL wasn't entitled to attorney-client privilege for the information.

Teva made the request to support its...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.